The import of heterocyclic compounds with N-hetero-atom(s) only to Canada is projected from $151.26 million in 2024, declining steadily to $129.16 million by 2028. In 2023, the import value stood at approximately $157 million. Year-on-year percentage changes indicate a consistent decrease, averaging around 4% annually, with a compound annual growth rate (CAGR) of -3.84% over the forecasted period.

Future trends to watch for include:

Potential changes in international trade policies or agreements influencing the import dynamics.
Technological advancements or substitutions impacting the demand for these compounds.
Global economic conditions and their effects on Canada's import capacity and needs.